Stefan Steidl

Years Active: 2022-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

R Leo Sakemura, Claudia Manriquez Roman, Paulina Horvei, Elizabeth L Siegler, James H Girsch, Olivia L Sirpilla, Carli M Stewart, Kun Yun, Ismail Can, Ekene J Ogbodo, Mohamad M Adada, Evandro D Bezerra, Lionel Aurelien Kankeu Fonkoua, Mehrdad Hefazi, Michael W Ruff, Brooke L Kimball, Long K Mai, Truc N Huynh, Wendy Nevala, Kristina Ilieva, Christian Augsberger, Maria Patra-Kneuer, Jürgen Schanzer, Jan Endell, Christina Heitmüller, Stefan Steidl, Sameer A Parikh, Wei Ding, Neil E Kay, Grzegorz S Nowakowski, Saad S Kenderian
CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS. Blood (2023)
Jung Hyun Her, Dominik Pretscher, Maria Patra-Kneuer, Juergen Schanzer, Sung Yoo Cho, Yu Kyeong Hwang, Timm Hoeres, Rainer Boxhammer, Christina Heitmueller, Martin Wilhelm, Stefan Steidl, Jan Endell
Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapy. Cancer immunology, immunotherapy : CII 71 (11) (2022)

Stefan Steidl.css-eqlu8i{font-size:small;padding-left:4px;}